Thrombosis Research
Volume 124, Issue 4 , Pages 418-422 , September 2009

Evaluation of the platelet count drop method for assessment of platelet function in comparison with “gold standard” light transmission aggregometry

  • Marie Lordkipanidzé

      Affiliations

    • Faculty of Pharmacy, Université de Montréal, Montréal, Canada
    • Research Center, Hôpital du Sacré-Cœur de Montréal, Montréal, Canada
    • Department of Pharmacy, Hôpital du Sacré-Cœur de Montréal, Montréal, Canada
    • ,
  • Chantal Pharand

      Affiliations

    • Faculty of Pharmacy, Université de Montréal, Montréal, Canada
    • Research Center, Hôpital du Sacré-Cœur de Montréal, Montréal, Canada
    • Department of Pharmacy, Hôpital du Sacré-Cœur de Montréal, Montréal, Canada
    • ,
  • Erick Schampaert

      Affiliations

    • Faculty of Medicine, Université de Montréal, Montréal, Canada
    • Research Center, Hôpital du Sacré-Cœur de Montréal, Montréal, Canada
    • Division of Cardiology, Hôpital du Sacré-Cœur de Montréal, Montréal, Canada
    • ,
  • Donald A. Palisaitis

      Affiliations

    • Faculty of Medicine, Université de Montréal, Montréal, Canada
    • Research Center, Hôpital du Sacré-Cœur de Montréal, Montréal, Canada
    • Division of Cardiology, Hôpital du Sacré-Cœur de Montréal, Montréal, Canada
    • ,
  • Jean G. Diodati

      Affiliations

    • Faculty of Medicine, Université de Montréal, Montréal, Canada
    • Research Center, Hôpital du Sacré-Cœur de Montréal, Montréal, Canada
    • Division of Cardiology, Hôpital du Sacré-Cœur de Montréal, Montréal, Canada
    • Corresponding Author InformationCorresponding author. Research Center, Hôpital du Sacré-Coeur de Montréal, 5400, boul. Gouin Ouest, Montréal, Québec, Canada H4J 1C5. Tel.: +1 514 338 2200; fax: +1 514 338 2694.

Received 5 December 2008 ,Revised 27 January 2009 ,Accepted 3 February 2009.

References 

  1. Patrono C, Baigent C, Hirsh J, Roth G. Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:199S–233S
  2. Fraker TD, Fihn SD, Gibbons RJ, Abrams J, Chatterjee K, Daley J, et al. 2007 chronic angina focused update of the ACC/AHA 2002 Guidelines for the management of patients with chronic stable angina. Circulation. 2007;116:2762–2772
  3. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71–86
  4. Lordkipanidzé M, Pharand C, Palisaitis DA, Diodati JG. Aspirin resistance : Truth or dare. Pharmacol Ther. 2006;112:733–743
  5. Nguyen TA, Diodati JG, Pharand C. Resistance to clopidogrel: a review of the evidence. J Am Coll Cardiol. 2005;45:1157–1164
  6. Wenaweser P, Dorffler-Melly J, Imboden K, Windecker S, Togni M, Meier B, et al. Stent thrombosis is associated with an impaired response to antiplatelet therapy. J Am Coll Cardiol. 2005;45:1748–1752
  7. Cuisset T, Frere C, Quilici J, Barbou F, Morange PE, Hovasse T, et al. High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome. J Thromb Haemost. 2006;4:542–549
  8. Gianetti J, Parri MS, Sbrana S, Paoli F, Maffei S, Paradossi U, et al. Platelet activation predicts recurrent ischemic events after percutaneous coronary angioplasty: a 6 months prospective study. Thromb Res. 2006;118:487–493
  9. Foussas SG, Zairis MN, Patsourakos NG, Makrygiannis SS, Adamopoulou EN, Handanis SM, et al. The impact of oral antiplatelet responsiveness on the long-term prognosis after coronary stenting. Am Heart J. 2007;154:676–681
  10. Cuisset T, Hamilos M, Sarma J, Sarno G, Wyffels E, Vanderheyden M, et al. Relation of low response to clopidogrel assessed with point-of-care assay to periprocedural myonecrosis in patients undergoing elective coronary stenting for stable angina pectoris. Am J Cardiol. 2008;101:1700–1703
  11. Michelson AD. Platelet function testing in cardiovascular diseases. Circulation. 2004;110:e489–e493
  12. Harrison P. Progress in the assessment of platelet function. Br J Haematol. 2000;111:733–744
  13. Nicholson N, Panzer-Knodle S, Haas N, Taite B, Szalony J, Page J, et al. Assessment of platelet function assays. Am Heart J. 1998;135:S170–S178
  14. Lordkipanidzé M, Pharand C, Nguyen TA, Schampaert E, Palisaitis DA, Diodati JG. Comparison of four tests to assess inhibition of platelet function by clopidogrel in stable coronary artery disease patients. Eur Heart J. 2008;29:2877–2885
  15. Lordkipanidzé M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J. 2007;28:1702–1708
  16. Gum PA, Kottke-Marchant K, Welsh PA, White J, Topol EJ. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol. 2003;41:961–965
  17. Frere C, Cuisset T, Quilici J, Camoin L, Carvajal J, Morange PE, et al. ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome. Thromb Haemost. 2007;98:838–843
  18. Buonamici P, Marcucci R, Migliorini A, Gensini GF, Santini A, Paniccia R, et al. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. J Am Coll Cardiol. 2007;49:2312–2317
  19. Geisler T, Grass D, Bigalke B, Stellos K, Drosch T, Dietz K, et al. The Residual Platelet Aggregation after Deployment of Intracoronary Stent (PREDICT) score. J Thromb Haemost. 2008;6:54–61
  20. Rand ML, Leung R, Packham MA. Platelet function assays. Transfus Apher Sci. 2003;28:307–317
  21. Ryan WL, Hakenkamp K, Sullivan E. A new platelet function test. Thromb Res. 1990;58:163–173
  22. Lau WC, Walker CT, Obilby D, Wash MM, Carville DG, Guyer KE, et al. Evaluation of a BED-SIDE Platelet Function Assay: Performance and Clinical Utility. Ann Card Anaesth. 2002;5:33–42
  23. Campbell J, Ridgway H, Carville D. Plateletworks®: a novel point of care platelet function screen. Mol Diagn Ther. 2008;12:253–258
  24. Lennon MJ, Gibbs NM, Weightman WM, McGuire D, Michalopoulos N. A comparison of Plateletworks and platelet aggregometry for the assessment of aspirin-related platelet dysfunction in cardiac surgical patients. J Cardiothorac Vasc Anesth. 2004;18:136–140
  25. Mobley JE, Bresee SJ, Wortham DC, Craft RM, Snider CC, Carroll RC. Frequency of nonresponse antiplatelet activity of clopidogrel during pretreatment for cardiac catheterization. Am J Cardiol. 2004;93:456–458
  26. Craft RM, Chavez JJ, Snider CC, Muenchen RA, Carroll RC. Comparison of modified Thrombelastograph and Plateletworks whole blood assays to optical platelet aggregation for monitoring reversal of clopidogrel inhibition in elective surgery patients. J Lab Clin Med. 2005;145:309–315
  27. Van Werkum JW, Kleibeuker M, Postma S, Bouman HJ, Elsenbert EHAM, Ten Berg JM, et al. A comparison between the Plateletworks-assay and light transmittance aggregometry for monitoring the inhibitory effects of clopidogrel. Int J Cardiol. 2008;
  28. Santos MT, Valles J, Marcus AJ, Safier LB, Broekman MJ, Islam N, et al. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment. J Clin Invest. 1991;87:571–580
  29. Valles J, Santos MT, Aznar J, Osa A, Lago A, Cosin J, et al. Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality : the effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of erythrocytes on platelet reactivity. Circulation. 1998;97:350–355
  30. Patrignani P. Aspirin insensitive eicosanoid biosynthesis in cardiovascular disease. Thromb Res. 2003;110:281–286
  31. Heptinstall S, Johnson A, Glenn JR, White AE. Adenine nucleotide metabolism in human blood–important roles for leukocytes and erythrocytes. J Thromb Haemost. 2005;3:2331–2339
  32. Dyszkiewicz-Korpanty AM, Frenkel EP, Sarode R. Approach to the assessment of platelet function: comparison between optical-based platelet-rich plasma and impedance-based whole blood platelet aggregation methods. Clin Appl Thromb Hemost. 2005;11:25–35

PII: S0049-3848(09)00097-8

doi: 10.1016/j.thromres.2009.02.002

Thrombosis Research
Volume 124, Issue 4 , Pages 418-422 , September 2009

Article Tools

* Image Usage & Resolution